|
|
 | | | |
- close
- close
- close
- close
| |||||||||
ASPM » Topics » Failure of users of the BIS system, or users of future products we may develop, to obtain adequate reimbursement from third-party payors could limit market acceptance of the BIS system and other products, which could prevent us from sustaining profitabiliThese excerpts taken from the ASPM 10-K filed Mar 6, 2009. Failure
of users of the BIS system, or users of future products we may
develop, to obtain adequate reimbursement from third-party
payors could limit market acceptance of the BIS system and other
products, which could prevent us from sustaining
profitability.
Anesthesia providers are generally not reimbursed separately for
patient monitoring activities utilizing the BIS system. For
hospitals and outpatient surgical centers, when reimbursement is
based on charges or costs, patient monitoring with the BIS
system may reduce reimbursements for surgical procedures,
because charges or costs may decline as a result of monitoring
with the BIS system. Failure by hospitals and other users of the
BIS system to obtain adequate reimbursement from third-party
payors, or any reduction in the reimbursement by third-party
payors to hospitals and other users as a result of using the BIS
system, could limit market acceptance of the BIS system, which
could prevent us from sustaining profitability.
In addition, market acceptance of future products serving the
depression and Alzheimer’s disease markets could depend
upon adequate reimbursement from third-party payors. The ability
and willingness of third-party payors to authorize coverage and
sufficient reimbursement to compensate and encourage physicians
to use such products is uncertain.
Failure of users of the BIS system, or users of future products we may develop, to obtain adequate reimbursement from third-party payors could limit market acceptance of the BIS system and other products, which could prevent us from sustaining profitability. Anesthesia providers are generally not reimbursed separately for patient monitoring activities utilizing the BIS system. For hospitals and outpatient surgical centers, when reimbursement is based on charges or costs, patient monitoring with the BIS system may reduce reimbursements for surgical procedures, because charges or costs may decline as a result of monitoring with the BIS system. Failure by hospitals and other users of the BIS system to obtain adequate reimbursement from third-party payors, or any reduction in the reimbursement by third-party payors to hospitals and other users as a result of using the BIS system, could limit market acceptance of the BIS system, which could prevent us from sustaining profitability. In addition, market acceptance of future products serving the depression and Alzheimer’s disease markets could depend upon adequate reimbursement from third-party payors. The ability and willingness of third-party payors to authorize coverage and sufficient reimbursement to compensate and encourage physicians to use such products is uncertain. These excerpts taken from the ASPM 10-K filed Mar 17, 2008. Failure
of users of the BIS system, or users of future products we may
develop, to obtain adequate reimbursement from third-party
payors could limit market acceptance of the BIS system and other
products, which could prevent us from sustaining
profitability.
Anesthesia providers are generally not reimbursed separately for
patient monitoring activities utilizing the BIS system. For
hospitals and outpatient surgical centers, when reimbursement is
based on charges or costs, patient monitoring with the BIS
system may reduce reimbursements for surgical procedures,
because charges or costs may decline as a result of monitoring
with the BIS system. Failure by hospitals and other users of the
BIS system to
Table of Contents
obtain adequate reimbursement from third-party payors, or any
reduction in the reimbursement by third-party payors to
hospitals and other users as a result of using the BIS system,
could limit market acceptance of the BIS system, which could
prevent us from sustaining profitability.
In addition, market acceptance of future products serving the
depression and Alzheimer’s disease markets could depend
upon adequate reimbursement from third-party payors. The ability
and willingness of third-party payors to authorize coverage and
sufficient reimbursement to compensate and encourage physicians
to use such products is uncertain.
Failure of users of the BIS system, or users of future products we may develop, to obtain adequate reimbursement from third-party payors could limit market acceptance of the BIS system and other products, which could prevent us from sustaining profitability. Anesthesia providers are generally not reimbursed separately for patient monitoring activities utilizing the BIS system. For hospitals and outpatient surgical centers, when reimbursement is based on charges or costs, patient monitoring with the BIS system may reduce reimbursements for surgical procedures, because charges or costs may decline as a result of monitoring with the BIS system. Failure by hospitals and other users of the BIS system to
Table of Contentsobtain adequate reimbursement from third-party payors, or any reduction in the reimbursement by third-party payors to hospitals and other users as a result of using the BIS system, could limit market acceptance of the BIS system, which could prevent us from sustaining profitability. In addition, market acceptance of future products serving the depression and Alzheimer’s disease markets could depend upon adequate reimbursement from third-party payors. The ability and willingness of third-party payors to authorize coverage and sufficient reimbursement to compensate and encourage physicians to use such products is uncertain. This excerpt taken from the ASPM 8-K filed Jun 13, 2007. Failure of users
of the BIS system, or users of future products we may develop,
to obtain adequate reimbursement from third-party payors could
limit market acceptance of the BIS system and other
products, which could prevent us from sustaining
profitability.
Anesthesia providers are generally not reimbursed separately for
patient monitoring activities utilizing the BIS system. For
hospitals and outpatient surgical centers, when reimbursement is
based on charges or costs, patient monitoring with the BIS
system may reduce reimbursements for surgical procedures,
because charges or costs may decline as a result of monitoring
with the BIS system. Failure by hospitals and other users of the
BIS system to obtain adequate reimbursement from third-party
payors, or any reduction in the reimbursement by third-party
payors to hospitals and other users as a result of using the BIS
system, could limit market acceptance of the BIS system, which
could prevent us from sustaining profitability.
In addition, market acceptance of future products serving the
depression and Alzheimer’s disease markets could depend
upon adequate reimbursement from third-party payors. The ability
and
Table of Contents
willingness of third-party payors to authorize coverage and
sufficient reimbursement to compensate and encourage physicians
to use such products is uncertain.
This excerpt taken from the ASPM 10-K filed Mar 15, 2007. Failure
of users of the BIS system, or users of future products we may
develop, to obtain adequate reimbursement from third-party
payors could limit market acceptance of the BIS system and other
products, which could prevent us from sustaining
profitability.
Anesthesia providers are generally not reimbursed separately for
patient monitoring activities utilizing the BIS system. For
hospitals and outpatient surgical centers, when reimbursement is
based on charges or costs, patient monitoring with the BIS
system may reduce reimbursements for surgical procedures,
because charges or costs may decline as a result of monitoring
with the BIS system. Failure by hospitals and other users of the
BIS system to obtain adequate reimbursement from third-party
payors, or any reduction in the reimbursement by third-party
Table of Contents
payors to hospitals and other users as a result of using the BIS
system could limit market acceptance of the BIS system, which
could prevent us from sustaining profitability.
In addition, market acceptance of future products serving the
depression and Alzheimer’s disease markets could depend
upon adequate reimbursement from third-party payors. The ability
and willingness of third-party payors to authorize coverage and
sufficient reimbursement to compensate and encourage physicians
to use such products is uncertain.
| EXCERPTS ON THIS PAGE:
|
| |||||||
